Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹498 Cr₹532 Cr₹662 Cr₹392 Cr₹84 Cr

What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of EMCURE PHARMACEUTICALS is ₹498 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹498 Cr
Mar2023₹532 Cr
Mar2022₹662 Cr
Mar2021₹392 Cr
Mar2020₹84 Cr

How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹498 Cr
-6.36
Mar2023 ₹532 Cr
-19.66
Mar2022 ₹662 Cr
68.87
Mar2021 ₹392 Cr
369.04
Mar2020 ₹84 Cr -

Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹25,845.0 Cr 6.3% 2.8% -0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,091.0 Cr 2.3% 3.2% 9.5% Stock Analytics
DIVIS LABORATORIES ₹181,302.0 Cr -0.2% 4.5% 49.6% Stock Analytics
CIPLA ₹119,038.0 Cr -0.2% -2% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹117,170.0 Cr 3.7% 6.5% 16.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,061.0 Cr -0% -4.6% -6.2% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

6.3%

2.8%

-0.1%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses